Financial support and resources available for businesses impacted by COVID-19.

Support for businesses impacted by COVID-19.

NeurAxon Inc.

NeurAxon is a leader in discovering and developing next-generation pain therapeutics focused on the inhibition of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating chronic pain and central nervous system neuronal sensitization.

Investment year: 2007
Industry sector: Biotechnology
Region: Ontario
Website
Follow NeurAxon Inc.